According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda). The drug is one of the first checkpoint inhibitors to be developed and used in cancer treatment. The findings are published online today in the Journal of Clinical Oncology.
Read More
Author: sh ytlk
Study shows UV technology raises the standard in disinfecting ORs and medical equipment
Ultraviolet (UV) technology developed by the New York-based firm PurpleSun Inc. eliminates more than 96 percent of pathogens in operating rooms (ORs) and on medical equipment, compared to 38 percent using manual cleaning methods that rely on chemicals to disinfect surfaces, according to a study published this month in the American Journal of Infection Control (AJIC).
Read More
Clinical trial exposes deadly kidney cancer’s Achilles’ heel
An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target. The finding from a team of researchers at the UT Southwestern Medical Center’s Kidney Cancer Program, published in the Feb. 15 issue of Clinical Cancer Research, reveals a weakness in this cancer that could be further exploited with other targeted treatments in the future.
Read More
How ‘Stranger Things’ widened awareness of a rare disorder
(HealthDay)—Teenage actor Gaten Matarazzo III was born with a rare genetic disorder that affects bone development. And ever since his Netflix series “Stranger Things” became a hit, public interest in the condition has shot up, a new study finds.
Read More
Earth-based or star-bound, heed these heart-healthy lessons from space
On Feb. 20, 1962, John Glenn made history when he became the first American to orbit the Earth.
Read More
Polymer-based stents noninferior for patients with high bleeding risk
(HealthDay)—Polymer-based zotarolimus-eluting stents are noninferior to polymer-free drug-coated stents among patients at high bleeding risk undergoing percutaneous coronary intervention (PCI), according to a study published online Feb. 12 in the New England Journal of Medicine.
Read More
Amid protests, Portugal lawmakers vote to allow euthanasia
Portugal’s parliament voted Thursday in favor of allowing euthanasia and physician-assisted suicide for terminally ill people.
Read More
Euthanasia’s legal status in Europe
Euthanasia is legal in only three European countries while others allow terminally ill people to refuse life-maintaining treatment or to have help to die.
Read More
Three new coronavirus cases in Iran after two deaths
Iran has confirmed three new coronavirus cases following the deaths of two elderly men, the health ministry told AFP on Thursday, as Iraq banned travel to and from its neighbour.
Read More
Developmental disability diagnosis more likely in rural children
(HealthDay)—Children living in rural areas are more likely to be diagnosed with a developmental disability compared with those living in urban areas, according to a study published online Feb. 19 in National Health Statistics Reports, a publication from the U.S. Centers for Disease Control and Prevention.
Read More